Abstract
Conditioned medium obtained from bone marrow-derived stem cells has been proposed as a novel cell-free therapy in spinal cord injury and neuropathic pain, yet the direct effect on spinal neuron function has never been investigated. Here, we adopted spinal cord organotypic cultures (SCOCs) as an experimental model to probe the effect of ST2 murine mesenchymal stem cells-conditioned medium (ST2-CM) on dorsal horn (DH) neuron functional properties. Three days of SCOC exposure to ST2-CM increased neuronal activity measured by Fos expression, as well as spontaneous or induced firing. We showed that the increase in neuronal excitability was associated with changes in both intrinsic membrane properties and an enhanced excitatory drive. The increased excitability at the single-cell level was substantiated at the network level by detecting synchronous bursts of calcium waves across DH neurons. Altogether, SCOCs represent a viable tool to probe mesenchymal cells' effect on intact neuronal networks. Our findings indicate that ST2-CM enhances neuronal activity and synaptic wiring in the spinal dorsal horn. Our data also support the trophic role of mesenchymal cells CM in maintaining network activity in spinal circuits.
Graphical Abstract
Similar content being viewed by others
Introduction
Mesenchymal stem cells (MSC) represent a versatile and attractive tool in cell-based therapy for brain repair due to their broad availability in peripheral tissues (e.g. bone marrow or adipose tissue) of adult donors and their capacity to restore homeostatic conditions in different altered areas of the nervous system [1, 2].
In recent years, a growing body of evidence suggests that MSC-derived conditioned media (MSC-CM) have a strong neuroprotective effect in different neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and spinal cord injury [3,4,5,6]. Neuroprotection is believed to be due to the secretome released by MSC that contains several neuroactive and immunomodulatory molecules promoting neuronal survival, local angiogenesis, and reducing neuroinflammation [7,8,9]. It remains unclear whether these molecules are freely secreted into the culture medium and/or packed into extracellular vesicles (EV) that act as cargoes for their transport outside the cell [10].
The main advantage of using cell-free conditioned media, as compared to MSC transplantation, is the reduced occurrence of side effects due to the low survival rate of exogenous cells, as well as the immunological responses and rejection mechanisms in host tissues [11]. On the other hand, the safe and rational use of conditioned media in clinical settings requires proper preclinical validation.
In vivo models have been largely used in preclinical studies to demonstrate the efficacy and safety of conditioned media in neurological disorders [3, 12,13,14,15,16]; yet, in vivo procedures are technically demanding, time-consuming, quite expensive, and require a relatively high number of experimental animals [17].
The organotypic slice cultures of nervous tissue are an ex vivo culture model that maintains most of the histological organization and functional properties of the local neural circuitries for several weeks [18]. In particular, the thickness and accessibility of organotypic culture allow for studying the impact of prolonged experimental treatments on both morphological and physiological features of the neuronal networks [19,20,21]. For these reasons, organotypic cultures represent a convenient link between in vitro and in vivo models, having a higher level of complexity as compared to cell cultures, but being more permissive than intact animals for analyzing in depth the cellular and molecular profiles of the nervous system, while reducing the number of experimental animals [17, 20].
In this study, we propose to use spinal cord organotypic cultures (SCOCs) from postnatal mice to study the effects of medium conditioned by ST2 murine bone marrow-derived mesenchymal cell line (ST2-CM, [22]). Specifically, we focused on the spinal dorsal horn (DH, [23, 24]), which represents a key central area for the integration of sensory input and a critical site for the development of altered sensory encoding following peripheral nerve and spinal cord injury [25, 26]. We analyzed the impact of ST2-CM on DH network excitability and connectivity by combining functional data from single neurons obtained by patch-clamp recordings with a broader analysis of local neuron activity by calcium imaging.
Materials and Methods
Animals
All experimental procedures were approved by the Italian Ministry of Health (authorization 485/2017-PR) and maintained according to the NIH Guide for the Care and Use of Laboratory Animals and to current EU and Italian regulations. Male and female CD1 mice were housed in a controlled and enriched environment and maintained on a 12/12-h light/dark cycle with food and water ad libitum.
ST2 Cell Culture and Conditioned Medium (CM) Preparation
Bone-marrow-derived murine ST2 cells were a kind gift from Professor Rhodri Ceredig (National University of Ireland Galway, Ireland).
Cells were initially cultured in standard growth medium, consisting of Dulbecco's modified Eagle medium/F-12 + GlutaMAX™ (DMEM/F-12), supplemented with 1% penicillin/streptomycin (P/S) and 10% fetal bovine serum (FBS) (all Gibco®, Life Technologies™, Paisley, UK) at 37 °C/5% CO2. Cultures reaching 80% confluence were passaged using 0.25% trypsin–EDTA (Gibco®, Life Technologies™).
ST2 cells were seeded into a T75 culture flask at a density of 20,000 cells/cm2 in 15 ml DMEM/F-12 and incubated overnight at 37 °C/5% CO2 to allow cell adherence. ST2 cells were washed once with phosphate-buffered saline (PBS) and subsequently cultured in 15 ml of Neurobasal medium, composed of Neurobasal A medium) supplemented with 2% 50× B27 supplement (V/V), 1% 200 mM l-glutamine (V/V), and 1% antibiotic/antimycotic (V/V)(all Gibco®, ThermoFisher Scientific, USA) to generate an appropriate conditioned medium CM for subsequent assays on spinal slices. CM was harvested after a further 3 days of incubation, filter sterilized (0.2 μm), and stored at − 80 °C in 1.5 ml aliquots. Control medium samples minus cells were prepared in tandem, following the same protocol.
For a set of experiments, ST2-CM was deprived of EVs [27, 28]. In brief, ST2-CM was centrifuged initially for 20 min at 2,000 g at 4 °C, the supernatant removed and filtered (0.2 μm), before loading onto a 30% sucrose cushion, made using D2O (Sigma), and centrifuging at 100,000g for 105 min at 4 °C using an SW28 Ti rotor. The sucrose cushion, washed with at least 1:1 filtered PBS, was then subjected to final centrifugation at 100,000 g for 70 min in a Type 70 Ti fixed angle rotor to pellet EVs, whilst the remaining EV-depleted supernatant was filter sterilized (0.2 μm) and stored at -80 oC.
SCOC Preparation
SCOCs were prepared as previously described [23, 24]. Briefly, mice were euthanized with a lethal dose of sodium pentobarbital (60 mg/100 g, intraperitoneal). Then, a dorsal laminectomy was performed in an ice-cold cutting solution (containing in mM: 130 N-Methyl-D-glucamine, 10 Glucose, 26 NaHCO3, 1.25 NaH2PO4, 5 MgCl2, 0.5 CaCl2, 3.5 KCl, and pH adjusted to 7.35). The spinal cord was dissected, the dura mater was gently removed and transverse slices (350 μm thick) were obtained using a vibratome (Leica VT 1200, Germany). The slices were placed on polycarbonate cell culture inserts (Millicell®, Merck, USA) with 0.4 µM pore size. The inserts were then placed in a 35 mm Petri dish containing 1 mL culture medium composed as follows: 50% Eagle’s Basal Medium (V/V), 25% horse serum (V/V), 25% Hanks balanced salt solution (V/V), 0.5% glucose (W/V), 0.5% 200 mM l-glutamine (V/V), and 1% antibiotic/antimycotic (V/V, all Gibco®, ThermoFisher Scientific, USA) and incubated at 34 °C/5% CO2. After 3.5 days serum-containing medium was substituted with serum-free Neurobasal medium (ThermoFisher Scientific) supplemented with B27 2% (V/V), L-glutamine 2% (V/V), and antibiotics/antimycotics 1% (V/V) for another 3.5 days. Then, slices were either cultured in Neurobasal™ medium (control condition) or the same medium previously conditioned with bone-marrow-derived murine ST2 cells (ST2-CM) for at least 3 days before the experiment (Fig. 1).
Patch-Clamp Recordings and Analysis
Recordings were performed as described [23]. SCOCs (DIV > 10) were excised from the inset by cutting the membrane around the slice with a razor blade. The slice and its attached membrane were placed in a recording chamber where were constantly perfused with artificial cerebrospinal fluid (aCSF) at 2 ml/min and bubbled with carbogen (O2 95%/CO2 5%). The aCSF composition was (mM): 126 NaCl, 26 NaHCO3, 2.5 KCl, 2 CaCl2, 2 MgCl2, 10 Glucose, 1.25 NaH2PO4. The chamber was fixed in a bright field inverted microscope (Eclipse FN-1, Nikon Inc., Japan) equipped with infrared light. Patch-clamp recordings were obtained from visually identified neurons in the spinal dorsal horn by a MultiClamp 700B amplifier (Molecular Devices, USA) and digitized by Digidata 1550b at 20 kHz and filtered at 2.5 kHz. Patch-clamp recordings were obtained in whole-cell configuration (both voltage- and current-clamp modes) and acquired with Clampex software (Molecular Devices). Borosilicate patch pipettes with an average resistance of 5 MΩ were filled with intracellular solution containing (mM): 125 K-gluconate, 20 KCl, 5 EGTA, 2 MgCl2, 10 HEPES, 2 ATPNa, 0.2 GTPNa, pH 7.2 (with KOH). All voltage values were corrected offline for liquid junction potential (13.7 mV). Voltage clamp recordings were performed at the holding potential of -70 mV. Current-clamp recordings were obtained either at the resting membrane potential to study spontaneous activity or following the injection of current in 10 pA current-step protocol. The data were analyzed offline with pClamp 10.7.0.3 software (Molecular Devices) for current clamp data or Minianalysis software (Synaptosoft, USA) for voltage clamp data.
Calcium Imaging Recordings and Analysis
Calcium imaging was performed as previously described [24]. Briefly, SCOCs were loaded with the calcium dye Oregon Green® 488 BAPTA-1, AM (Ex 494, Em 523 nm, ThermoFisher) at 10 µM final concentration with Pluronic F-127 acid 0.04% (W/V), and DMSO at 0.3% (V/V), in 1 ml of Neurobasal medium. Slices were incubated for one hour at 37 °C and 5% CO2. Calcium imaging recordings were taken in aCSF bubbled with carbogen by a confocal microscope (Leica, TCS SP5). Images were acquired at 4.9 Hz with a 40× water immersion objective. We selected regions of interest (ROIs) from each digital file with ImageJ software (NIH, USA) for analysis. Changes in fluorescence intensity were plotted in a cartesian chart (intensity, Y-axis; time, X-axis). The fluctuations of fluorescence intensities along the x-axis were analyzed by Clampfit 10.7.0.3 (Molecular Devices) with the “Threshold Search” tool to detect calcium waveforms as positive-ongoing events. The fluorescence bleaching in the file was corrected with Clampfit 10.7.0.3 (Molecular Devices). The threshold for event detection was set to avoid the baseline noise. Bursts were defined as multipeaked waveforms in which one waveform rises in the decay phase of the preceding one.
Immunohistochemistry
SCOCs were fixed for 1 h at RT in 4% paraformaldehyde (in PB 0.1M, pH 7.4). Following repeated washes with PBS 0.05M, pH 7.4, slices were incubated for 1 h in blocking buffer (PBS containing 1% of normal goat serum and 0.1% Triton-X) at RT. Slices were then incubated overnight at +4 °C with a primary monoclonal antibody raised in rabbits against the Fos protein (1/500; Cell Signaling Technology, cat.# 2250S, USA). Slices were repeatedly washed in PBS and incubated with goat anti-rabbit Alexa-488 secondary antibody (1/500; Invitrogen, USA) in PBS for 3 h at RT. After further washes, slices were mounted using an anti-fade fluorescence-free mounting solution (Sigma). Images were acquired in z-stack (1 µm steps) with a Leica TCS SP5 confocal microscope equipped with a 20× objective. Laser power, gain, and offset were initially set and maintained constant in all the acquisitions. Images were converted to an 8-bit grayscale format and subsequently analyzed with ImageJ software (NIH, Bethesda, Maryland, USA). After delineating the boundaries of the DH laminae according to previous anatomical criteria [29], the immunopositive signal was analyzed by selecting an appropriate threshold. The number of Fos+ cell bodies in the dorsal horn was counted with the “analyze particles” tool of ImageJ and expressed as the number of cells per area (cell density).
Statistics
Statistical analysis was performed by GraphPad Prism 9 (GraphPad Software, USA). Samples were compared by using an unpaired t-test for independent samples (two-tailed, unless otherwise stated), one-way- or two-way analysis of variance (ANOVA) for interactions between treatment and other variables. All data were reported as mean ± SEM, with n indicating the number of cells, unless otherwise stated. Values of P < 0.05 were considered statistically significant.
Results
Culturing SCOCs in ST2-CM Increases DH Neuronal Activation
Murine SCOCs were exposed either to the control medium (Neurobasal) or the ST2 cell conditioned medium (ST2-CM) from DIV 8 to 11 before the experimental procedures (see Fig. 1). In the DH, ST2-CM significantly increased the density of cells expressing Fos, a well-established marker of neuronal activation [30, 31] (Fig. 2a–b), which suggested an increased neuronal activity. A similar increase was also induced by EV-deprived ST2-CM, which suggests that neuronal activation was triggered by factors dissolved into the soluble fraction of the medium.
ST2-CM Increases Intrinsic DH Excitability
To address the impact of ST2-CM on neuronal excitability we recorded the spontaneous firing activity of SCOC DH neurons at rest in the current clamp configuration (Fig. 3a–b). While only half of the control neurons exhibited spontaneous action potentials (APs—13 out of 18), firing was observed in about two-thirds of the neurons exposed to ST2-CM (8 out of 17; Fig. 3c). The spontaneous firing frequency was higher in ST2-CM treated neurons (Fig. 3d), while the AP amplitude was unchanged (Fig. 3e). A slight change in AP kinetics was also observed (Fig. 3f), as APs from ST2-CM treated neurons displayed faster rise (Fig. 3g) and decay time (Fig. 3h). Subsequently, we applied a current step protocol to evaluate the impact of ST2-CM on the input–output properties of DH neurons (Fig. 4a–b). The obtained firing patterns (suppl. Fig. 1) corresponded to that described in our previous study on organotypic cultures [23], thus reflecting the heteoregeneity of neuronal cell types in the DH. In both control and ST2-CM treated neurons, we observed a progressive increase in the evoked firing rate along with the increase of the depolarizing step size. However, while in control, the increase in AP frequency induced by the depolarizing steps reached a plateau around 70 pA, after which a further increase in depolarization failed to increase the firing rate (Fig. 4c), in ST2-CM treated cells the number of APs kept growing until the 100 pA (Fig. 4c). Moreover, the rheobase calculated from the current step protocol was lower in ST2-CM treated neurons as compared to control neurons (Fig. 4d) and the AP frequency at the rheobase was significantly higher (Fig. 4e).
The increased excitability in SCOCs could be due to a change in the intrinsic membrane properties of the neurons, but could also account for an increased excitatory input. To address this latter point, we recorded spontaneous excitatory post-synaptic currents (sEPSCs) in voltage clamp at -70 mV (Fig. 5a–b). Interestingly, the frequency of sEPSCs was not affected by ST2-CM (Fig. 5c). Yet, the sEPSC amplitude was increased in ST2-CM treated cells, suggesting an increased excitatory drive (Fig. 5d).
Altogether, these data indicate that DH neurons exposed to ST2-CM displayed increased excitability, which was largely due to altered intrinsic membrane properties. The increased amplitude in sEPSCs can also be explained in terms of postsynaptic alterations (i.e., in the kinetics of the glutamate receptors) and/or a consequence of a higher-level of synchronization in the neuronal network (i.e., leading to a more synchronous release of glutamate).
ST2-CM Treatment Potentiates Calcium Transients in the DH of SCOCs
While single-cell recordings provide a high-resolution tool to investigate neuronal excitability, the approach does not allow to probe multiple neurons from the same network simultaneously. To address this point, we decided to image neuronal activity in the DH by calcium imaging (Fig. 6a). Recordings from multiple ROIs drawn around single cells show spontaneous calcium transients that often appear in synchronized patterns (Fig. 6b). The observed calcium transients are compatible with those described in neurons [32]. The overall transient frequency is not significantly increased following the exposure to ST2-CM, although a tendency can be observed at least in a subpopulation of cells (one-tailed unpaired t-test, P = 0.046; Fig. 6c). However, we noticed that the calcium waveforms in ST2-CM treated neuron are often organized in complex bursts (Fig. 6d). Indeed, bursts were detected in 37% of the ST2-CM treated DH neurons, but only in 18% of the control neurons (Fig. 6e). Moreover, bursts in neurons exposed to ST2-CM displayed more peaks than in control neurons (Fig. 6f) and a larger area under the curve (Fig. 6g).
Overall, CM potentiated the calcium transients in the DH of SCOCs by shifting calcium transients from an asynchronous single peak pattern to synchronous multipeaked waveforms, indicating a more robust organization of excitatory synaptic connectivity following ST2-CM medium treatment.
Discussion
In the present study, we characterized the functional impact of CM from bone marrow-derived mesenchymal ST2 cells on organotypically cultured spinal cord DH neurons. Our findings demonstrate that soluble factors released by ST2 cells in the culturing medium increase neuronal excitability and improve network activity.
CMs represent an attractive cell-free approach to counteract several neurological diseases [6, 33, 34]. In particular, CM from bone marrow-derived MSC improved functional recovery after spinal cord injury in rats [13, 16, 35] and alleviated neuropathic pain symptoms after nerve injury [36, 37].
Overall, our data support the neurotrophic role of CM from bone marrow-derived MSC on cultured spinal DH neurons. We showed that exposure to an ST2-conditioned medium increases the overall activity of DH neurons and their firing rate. Since EVs released by MSC have been described to reduce neuroinflammation in vivo [9], alleviate neuropathic and inflammatory pain symptoms [38], and favor neuronal repair after spinal cord injury [39], we tested whether their release in our medium was responsible for the increased spinal neuron activation. However, depleting the medium from EVs did not affect its capacity to increase FOS, thus suggesting that, in our model, neuronal activity is mainly modulated by soluble factors.
Our data are consistent with previous studies showing that MSC-CM increases and restores Fos reactivity in injured central neurons in vivo [40]. Similarly, CM derived from umbilical MSC was shown to foster firing activity in genetically altered induced pluripotent stem cell (iPSC)-derived neurons confirming that factors released in the medium may have a positive modulatory effect on neuronal excitability [41]. However, the real functional impact of CM on neuronal activity has been poorly analyzed in previous studies in vitro. Besides confirming a general increase in excitability, our study highlights a direct impact of ST2-CM on active membrane properties of DH neurons as indicated by the decrease in rheobase, the positive shift in input/output firing rate relationship, and the faster AP kinetics. Such changes are typically linked to changes in the composition and properties of voltage-gated potassium and sodium channels [42, 43]. In addition, we observed that the amplitude of sEPSCs was also increased (without a concomitant increase in frequency), which indicates an increased strength of glutamatergic transmission possibly due either to postsynaptic changes [44] or presynaptic plasticity [45]. The impact of increased neuronal excitability and excitatory drive on the overall network activity has been further investigated by the imaging of spontaneous calcium transients. Somatic calcium transients represent a good readout of firing activity [46] and, in spinal organotypic slices, they typically occur in synchronous patterns, especially in developing networks or in the presence of trophic factors [47, 48]. ST2-CM potentiated synchronous calcium transients in the DH by shifting the pattern of calcium waveforms from single spikes to multi-peaked bursts of activity. A more robust and synchronized burst activity suggests a better coupling between the pre-synaptic release of transmitters and the post-synaptic firing response. Since the coincidence of pre-and post-synaptic events is crucial for synaptic strength [49], our data support the role of ST2-CM in promoting synaptic connectivity in the CNS network, as previously experimentally observed by reducing synaptic inhibition or increasing excitation [49,50,51]. MSC-CM has been also shown to modulate axonal outgrowth in primary neuronal cultures [52], which may represent an additional mechanism to explain the increased connectivity in DH networks.
Altogether, the increased firing activity and intrinsic excitability of DH neurons, the enhanced glutamatergic input, and the synchronous calcium waveforms are typical hallmarks of network maturation and increased connectivity, suggesting an ST2-CM-dependent trophic/consolidating effect on the DH circuits [53]. The composition of CM secretome from mesenchymal stem cells has been investigated in previous studies [5, 54, 55]. Nakano et al. [56] reported that rat bone marrow stromal cells release several growth factors, including IGF-1, VEGF, TGFβ-1, and HGF. Similarly, Cantienieux et al. [13] identified in the same type of medium over twenty molecules involved in apoptosis, inflammation, angiogenesis, and neuromodulation, including neurotrophins such as NGF and BDNF. A similar composition has also been observed in human-derived MSC secretomes, either from bone marrow [57] or from dental pulp [58]. CM from mice bone marrow MSC has been less extensively analyzed, yet a recent study using a high-density protein array has identified up to 21 molecules and growth factors, among which HGF and VEGF [36]. Thus, the positive modulatory effect of ST2 cell secretome on DH neurons observed in the current study is likely due to a cocktail of factors, including neurotrophic factors, that strengthen neuronal activity and synaptic wiring in central circuits.
The DH circuits are critical for the correct encoding of sensory input and can undergo dramatic changes following peripheral nerve or spinal cord injury [25, 26]. Recently, it has been demonstrated that CM from mesenchymal stem cells alleviates neuropathic pain symptoms following nerve injury [36, 37] and is neuroprotective after spinal injury [13]. These important preclinical findings suggest that CM may represent a viable cell-free approach for the treatment of neurological diseases affecting the spinal neurons. Our data support this concept and provide for the first time direct evidence that CM from MSC acts as a positive neuromodulator in central circuits and promotes neuronal activity and synaptic connectivity in DH circuits. A limitation of this study is that the observed effect was not associated with a specific cell population in the DH, thus making more arbitrary any speculation on the direct functional impact on the sensory system, which can be however inferred from the above-cited investigations in vivo. On the other hand, being organotypic cultures a model in which a segment of the nervous system has been separated from its peripheral and central connections, the trophic effect exerted by the CM in stimulating neuronal activity and connectivity may explain how factors released by MSC may restore altered circuits in pathological conditions, such as nerve or spinal cord injury, in which proper neuronal connections are lost. Adopting organotypic cultures of central neurons for testing the efficacy of stem cell secretome represents an innovative strategy that may shorten the distance between preclinical studies and therapeutic application.
Data Availability
The datasets supporting the findings of this study are available upon reasonable request.
References
Andrzejewska, A., et al. (2021). Mesenchymal stem cells for neurological disorders. Advanced Science (Weinh), 8(7), 2002944.
Mariano, E. D., et al. (2015). Adult stem cells in neural repair: Current options, limitations and perspectives. World Journal of Stem Cells, 7(2), 477–482.
Abdelwahab, S. A., et al. (2021). Cerebral and cerebellar histological changes in the rat animal model of rotenone induced parkinsonism can be ameliorated by bone marrow derived stem cell conditioned media. Journal of Chemical Neuroanatomy, 111, 101892.
Chen, Y. T., et al. (2019). The superiority of conditioned medium derived from rapidly expanded mesenchymal stem cells for neural repair. Stem Cell Research & Therapy, 10(1), 390.
Makridakis, M., Roubelakis, M. G., & Vlahou, A. (2013). Stem cells: Insights into the secretome. Biochimica et Biophysica Acta, 1834(11), 2380–2384.
Sykova, E., Cizkova, D., & Kubinova, S. (2021). Mesenchymal stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis. Front Cell Dev Biol, 9, 695900.
Guy, R., & Offen, D. (2020). Promising opportunities for treating neurodegenerative diseases with mesenchymal stem cell-derived exosomes. Biomolecules, 10(9), 1320.
Muhammad, S. A. (2019). Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury. BioFactors, 45(6), 880–891.
Dabrowska, S., et al. (2019). Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats. Journal of Neuroinflammation, 16(1), 216.
Gemayel, J., et al. (2023). Mesenchymal stem cells-derived secretome and extracellular vesicles: Perspective and challenges in cancer therapy and clinical applications. Clinical and Translational Oncology, 25(7), 2056–2068.
Gunawardena, T. N. A., et al. (2019). Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine, 13(4), 569–586.
Aboutaleb, N., et al. (2019). Conditioned medium obtained from mesenchymal stem cells attenuates focal cerebral ischemia reperfusion injury through activation of ERK1/ERK2-BDNF signaling pathway. Journal of Chemical Neuroanatomy, 97, 87–98.
Cantinieaux, D., et al. (2013). Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: An original strategy to avoid cell transplantation. PLoS ONE, 8(8), e69515.
De Gregorio, C., et al. (2020). Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice. Stem Cell Research & Therapy, 11(1), 168.
Mathew, B., et al. (2019). Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials, 197, 146–160.
Tsai, M. J., et al. (2014). Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. Journal of Biomedical Science, 21(1), 5.
Daviaud, N., et al. (2013). Organotypic cultures as tools for optimizing central nervous system cell therapies. Experimental Neurology, 248, 429–440.
Gahwiler, B. H. (1984). Slice cultures of cerebellar, hippocampal and hypothalamic tissue. Experientia, 40(3), 235–243.
Humpel, C. (2015). Organotypic brain slice cultures: A review. Neuroscience, 305, 86–98.
Lossi, L., & Merighi, A. (2018). The use of ex vivo rodent platforms in neuroscience translational research with attention to the 3Rs philosophy. Frontiers in Veterinary Science, 5, 164.
Pandamooz, S., et al. (2016). Organotypic spinal cord culture: A proper platform for the functional screening. Molecular Neurobiology, 53(7), 4659–4674.
Tong, J., et al. (1999). A bone marrow-derived stroma cell line, ST2, can support the differentiation of fetal thymocytes from the CD4+ CD8+ double negative to the CD4+ CD8+ double positive differentiation stage in vitro. Immunology, 97(4), 672–678.
Ferrini, F., et al. (2010). Modulation of inhibitory neurotransmission by the vanilloid receptor type 1 (TRPV1) in organotypically cultured mouse substantia gelatinosa neurons. Pain, 150(1), 128–140.
Wood, C. R., et al. (2021). Mesenchymal stem cell conditioned medium increases glial reactivity and decreases neuronal survival in spinal cord slice cultures. Biochemistry and Biophysics Reports, 26, 100976.
Gwak, Y. S., & Hulsebosch, C. E. (2011). Neuronal hyperexcitability: A substrate for central neuropathic pain after spinal cord injury. Current Pain and Headache Reports, 15(3), 215–222.
West, S. J., et al. (2015). Circuitry and plasticity of the dorsal horn–toward a better understanding of neuropathic pain. Neuroscience, 300, 254–275.
Gupta, S., et al. (2018). An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem Cell Research & Therapy, 9(1), 180.
Hyland, M., et al. (2020). Pro-inflammatory priming of umbilical cord mesenchymal stromal cells alters the protein cargo of their extracellular vesicles. Cells, 9(3), 726.
Molander, C., Xu, Q., & Grant, G. (1984). The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. The Journal of Comparative Neurology, 230(1), 133–41.
Bullitt, E. (1990). Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. The Journal of Comparative Neurology, 296(4), 517–530.
Gao, Y. J., & Ji, R. R. (2009). c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? The Open Pain Journal, 2, 11–17.
Pasti, L., et al. (1997). Intracellular calcium oscillations in astrocytes: A highly plastic, bidirectional form of communication between neurons and astrocytes in situ. Journal of Neuroscience, 17(20), 7817–7830.
d’Angelo, M., Cimini, A., & Castelli, V. (2020). Insights into the effects of mesenchymal stem cell-derived Secretome in Parkinson’s disease. International Journal of Molecular Sciences, 21(15), 5241.
Zriek, F., Di Battista, J. A., & Alaaeddine, N. (2021). Mesenchymal stromal cell secretome: Immunomodulation, tissue repair and effects on neurodegenerative conditions. Current Stem Cell Research & Therapy, 16(6), 656–669.
Kanekiyo, K., et al. (2018). Effects of intrathecal injection of the conditioned medium from bone marrow stromal cells on spinal cord injury in rats. Journal of Neurotrauma, 35(3), 521–532.
Gama, K. B., et al. (2018). Conditioned medium of bone marrow-derived mesenchymal stromal cells as a therapeutic approach to neuropathic pain: A preclinical evaluation. Stem Cells International, 2018, 8179013.
Masoodifar, M., et al. (2021). Effect of the conditioned medium of mesenchymal stem cells on the expression levels of P2X4 and P2X7 purinergic receptors in the spinal cord of rats with neuropathic pain. Purinergic Signal, 17(1), 143–150.
Bryk, M., et al. (2022). Mesenchymal stem cells and extracellular vesicles for the treatment of pain: Current status and perspectives. British Journal of Pharmacology, 179(17), 4281–4299.
Sheng, Y., et al. (2021). MSC derived EV loaded with miRNA-22 inhibits the inflammatory response and nerve function recovery after spinal cord injury in rats. Journal of Cellular and Molecular Medicine, 25(21), 10268–10278.
Akhondzadeh, F., et al. (2020). Adipose-derived mesenchymal stem cells and conditioned medium attenuate the memory retrieval impairment during sepsis in rats. Molecular Neurobiology, 57(9), 3633–3645.
Zhao, H., et al. (2022). Ameliorating effect of umbilical cord mesenchymal stem cells in a human induced pluripotent stem cell model of Dravet syndrome. Molecular Neurobiology, 59(2), 748–761.
Routh, B. N., et al. (2017). Increased transient Na(+) conductance and action potential output in layer 2/3 prefrontal cortex neurons of the fmr1(-/y) mouse. Journal of Physiology, 595(13), 4431–4448.
Winbo, A., et al. (2020). Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells. American Journal of Physiology. Heart and Circulatory Physiology, 319(5), H927–H937.
Bellingham, M. C., Lim, R., & Walmsley, B. (1998). Developmental changes in EPSC quantal size and quantal content at a central glutamatergic synapse in rat. The Journal of Physiology, 511((Pt 3)(Pt 3)), 861–9.
Regehr, W. G. (2012). Short-term presynaptic plasticity. Cold Spring Harbor Perspectives in Biology, 4(7), a005702.
Ali, F., & Kwan, A. C. (2020). Interpreting in vivo calcium signals from neuronal cell bodies, axons, and dendrites: A review. Neurophotonics, 7(1), 011402.
Alles, S. R. A., et al. (2021). Chronic BDNF simultaneously inhibits and unmasks superficial dorsal horn neuronal activity. Science and Reports, 11(1), 2249.
Fabbro, A., et al. (2007). Activity-independent intracellular Ca2+ oscillations are spontaneously generated by ventral spinal neurons during development in vitro. Cell Calcium, 41(4), 317–329.
Murphy, T. H., et al. (1992). Spontaneous synchronous synaptic calcium transients in cultured cortical neurons. Journal of Neuroscience, 12(12), 4834–4845.
Ivenshitz, M., & Segal, M. (2010). Neuronal density determines network connectivity and spontaneous activity in cultured hippocampus. Journal of Neurophysiology, 104(2), 1052–1060.
Kuijlaars, J., et al. (2016). Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Science and Reports, 6, 36529.
Martins, L. F., et al. (2017). Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF. Science and Reports, 7(1), 4153.
Takada, N., Yanagawa, Y., & Komatsu, Y. (2005). Activity-dependent maturation of excitatory synaptic connections in solitary neuron cultures of mouse neocortex. European Journal of Neuroscience, 21(2), 422–430.
Paul, G., & Anisimov, S. V. (2013). The secretome of mesenchymal stem cells: Potential implications for neuroregeneration. Biochimie, 95(12), 2246–2256.
Wangler, S., et al. (2021). Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: A proteomic analysis. Stem Cell Research & Therapy, 12(1), 11.
Nakano, N., et al. (2010). Characterization of conditioned medium of cultured bone marrow stromal cells. Neuroscience Letters, 483(1), 57–61.
Teixeira, F. G., et al. (2017). Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson’s disease. Stem Cells Translational Medicine, 6(2), 634–646.
Gugliandolo, A., & Mazzon, E. (2021). Dental mesenchymal stem cell secretome: An intriguing approach for neuroprotection and neuroregeneration. International Journal of Molecular Sciences, 23(1), 456.
Acknowledgements
We thanks Prof. Rhodri Ceredig (National University of Ireland Galway, Ireland) for kindly providing ST2 cells.
Funding
Open access funding provided by Università degli Studi di Torino within the CRUI-CARE Agreement. This work was supported by the National Centre for the Replacement Refinement & Reduction of Animals in Research Crack It solution “Neuroinflammation and nociception in a dish” (https://nc3rs.org.uk/crackit/crack-it-news/new-solution-neuroinflammation-and-nociception-dish) fund.
Author information
Authors and Affiliations
Contributions
AM, FF and WEBJ conceived the project. Experimental procedures were designed and performed by EHJ, FF, CW, RD, OK; data analysis was performed by EHJ and FF; the manuscript was firstly drafted by FF and EHJ and revised by AM, CW and WEBJ. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethical Approval
All animal experiments were approved by the Italian Ministry of Health (authorization 485/2017-PR).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflicts of Interest/Competing Interests
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
12015_2023_10618_MOESM1_ESM.pdf
Supplementary file1 (PDF 1426 KB) Supplementary Figure 1. Representative firing patterns are obtained in response to injections of depolarizing currents. a-b. Tonic firing neurons. c. Delayed firing neuron. e. Phasic firing neuron. f. Single (or initial) firing neuron
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Juárez, E.H., Wood, C.R., Davies, R. et al. ST2-Conditioned Medium Fosters Dorsal Horn Cell Excitability and Synaptic Transmission in Cultured Mouse Spinal Cord. Stem Cell Rev and Rep 19, 2918–2928 (2023). https://doi.org/10.1007/s12015-023-10618-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-023-10618-x